Evidence map›Paper›PMID 32524704›Full record

ArticleCancer medicine2020

Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.

Salome Adam, Eva Martin-Diener, Bertrand Camey, Céline Egger Hayoz, Isabelle Konzelmann, Seyed Mohsen Mousavi, Christian Herrmann, Sabine Rohrmann, Miriam Wanner, Katharina Staehelin and 5 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. State of the science of sexual health among older cancer survivors: an integrative review.Journal of cancer survivorship : research and practice · 2025
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Salome AdamNational Institute for Cancer Epidemiology and Registration (NICER), c/o University of Zurich, Zurich, Switzerland.ORCID 0000-0002-1829-919X
Eva Martin-DienerDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Bertrand CameyFribourg Cancer Registry, Fribourg, Switzerland.
Céline Egger HayozFribourg Cancer Registry, Fribourg, Switzerland.
Isabelle KonzelmannHealth Observatory Valais, Valais Cancer Registry, Sion, Switzerland.
Seyed Mohsen MousaviCancer Registry East Switzerland, St. Gallen, Switzerland.
Christian HerrmannCancer Registry East Switzerland, St. Gallen, Switzerland.
Sabine RohrmannDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Miriam WannerDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Katharina StaehelinBasel Cancer Registry, Cantonal Department of Health, Basel, Switzerland.
Räto T StrebelDepartment of Urology, Graubünden Cantonal Hospital, Chur, Switzerland.
Marco RandazzoDepartment of Urology, Winterthur Cantonal Hospital, Winterthur, Switzerland.
Hubert JohnDepartment of Urology, Winterthur Cantonal Hospital, Winterthur, Switzerland.
Hans-Peter SchmidDepartment of Urology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.
Volker ArndtNational Institute for Cancer Epidemiology and Registration (NICER), c/o University of Zurich, Zurich, Switzerland.
University of Zurich · CHUniversity of St.Gallen · CHKantonsspital Winterthur · CHUniversity of Fribourg · CHGerman Cancer Research Center · DEHES-SO Valais-Wallis · CHHospital Base · CLKantonsspital Graubünden · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNerve-sparing (NS) surgery was developed to improve postoperative sexual and potentially urological outcomes after radical prostatectomy (RP). However, it is largely unknown how NSRP affects health-related quality of life (HRQoL) including urinary and sexual outcomes in prostate cancer (PC) survivors 5-10 years after diagnosis in comparison with Non-NSRP.

methodsThe study population included 382 stage pT2-T3N0M0 PC survivors 5-10 years post diagnosis, who were identified from the multiregional Prostate Cancer Survivorship in Switzerland (PROCAS) study. Briefly, in 2017/2018, PC survivors were identified via six population-based cancer registries based in both German- and French-speaking Switzerland. HRQoL and PC-specific symptom burden was assessed using the EORTC QLQ-C30 and EORTC QLQ-PR25 questionnaires. Differences in HRQoL outcomes between survivors treated with NSRP (uni- & bilateral) and Non-NSRP were analyzed with multivariable linear regression adjusted for age, years since diagnosis, cancer stage, comorbidities at diagnosis, and further therapies, if appropriate. Multiple imputation was performed to minimize the bias due to missing data.

resultsFive to ten years after diagnosis, PC survivors treated with NSRP and Non-NSRP reported similar symptom burden and comparable HRQoL function scores. The only significant differences were reported for sexual activity, whereas PC survivors who underwent NSRP reported statistically significant (P = .031) higher sexual activity than those on Non-NSRP. NSRP and Non-NSRP reported similar scores for urinary symptoms and all other HRQoL outcomes.

conclusionsOur results support nerve-sparing techniques as an option to improve postoperative sexual, but not urinary outcomes after RP in long-term PC survivors.

Indexed as

AgedCancer SurvivorsHumansMaleProstatectomyProstatic NeoplasmsQuality of Lifehealth-related quality of lifelong-term survivornerve-sparing radical prostatectomyprostate cancersexual outcomesurinary outcomes

Identifiers

PMID32524704
PMCPMC7402816
OpenAlexW3033237392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.